[Federal Register Volume 70, Number 28 (Friday, February 11, 2005)]
[Notices]
[Page 7279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-2645]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, National Cancer Institute.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute, Subcommittee 1--Clinical Sciences and
Epidemiology.
Date: March 7-8, 2005.
Open: March 7, 2005, 8:30 a.m. to 10:45 a.m.
Agenda: Joint Session of NCI, Board of Scientific Advisors and
BSC Subcommittees.
Place: National Institutes of Health, National Cancer Institute,
9000 Rockville Pike, Building 31, Conference Room 10, Bethesda, MD
20892.
Closed: March 7, 2005, 10:45 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, National Cancer Institute,
9000 Rockville Pike, Building 31, Conference Room 6, Bethesda, MD
20892.
Closed: March 8, 2005, 8 a.m. to 12:45 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: Holiday Inn Bethesda, Versailles IV, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Brian E. Wojcik, PhD, Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, 6116 Executive Boulevard, Room 2114,
Bethesda, MD 20892, (301) 496-7628, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 4, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-2645 Filed 2-10-05; 8:45 am]
BILLING CODE 4140-01-M